Invest in Our Future
Thank you for your interest in investing in Asclepiceutical AI.
Asclepiceuticals™ – The Sanctuary That Travels With You
Preventing Illness Before It Begins
Dear Investor,
Health has always been humanity’s greatest aspiration. For centuries, people sought sanctuaries of wisdom, healing, and renewal. Today, Asclepiceuticals AI (AAI) is bringing that sanctuary back — powered by science, guided by legacy, and built to travel with you for life.
At Asclepiceuticals AI, we are uniting ancient Asclepian medicine with modern AI to build a continuous, personalized system for preventive healthcare and longevity. At the core of this vision is the Asclepius family, a lineage and ethos of authentic care that unites wisdom, innovation, and continuity.
Progress to Date
- €4M flagship property on the Athens Riviera, now entering the architectural design phase.
- Winner: Best AI-Driven Biotech Innovation Platform 2025 (GHP Magazine).
- AI platform integrating 300+ digitized Asclepian formulations into a structured, machine-readable library.
- Strategic collaborations with leaders in preventive medicine, wellness tourism, and premium wellness brands.
Market Opportunity
Positioned across three converging sectors — AI healthcare, wellness tourism, and nutraceuticals — we are addressing a combined market opportunity of approximately €2.5T by 2034.
Wellness Tourism (€995B by 2030), Preventive Healthcare (€665B by 2030), and Nutraceuticals (€919B by 2034) together represent a multi-trillion-euro landscape. Yet, there is no integrated competitor at our level of authenticity, AI-enabled continuity, and longevity-driven wellness.
The Solution
AAI bridges this gap with a first-of-its-kind wellness ecosystem that offers:
AI-powered health profiling using genomics, microbiome & multi-omics data.
Personalized wellness & nutrition programs blending ancient wisdom with modern science.
Integrated luxury wellness travel and 24×7 app-based support.
High-margin functional food products & corporate wellness partnerships.
The Ask
We are raising €10M (flexible structure) to:
- Expand AI capabilities and deepen our preventive-health diagnostic library.
- Develop and establish Greece’s first AI-driven wellness center on the Athens Riviera, and scale strategic partnerships in preventive medicine and wellness tourism.
- Accelerate international expansion through a scalable digital wellness platform and a portfolio of nature-derived nutraceutical products.
In this round, investors are positioned for strong downside protection and significant growth potential through a diversified model that combines digital services, physical assets, and premium wellness products.
Team
AAI is led by Dr. Sven Rohmann, CEO & Co-Founder, together with a pioneering team of experts across healthcare, AI, and hospitality.
United by the Asclepius family ethos, this leadership group is committed to building an authentic, science-driven, and lifelong care ecosystem — ensuring health is not a transaction, but a journey.
Next Steps
We welcome a discussion on thesis, terms, and milestones.
A detailed plan, three-year financials, flagship architecture, and a data room are available on request.
We are not simply building a business — we are restoring what humanity has lost: a sanctuary of care that is authentic, protective, and enduring.
Together, as part of the Asclepius family, we invite you to shape the future of preventive medicine — elegant, timeless, and without walls.
Warm regards,
Dr. Sven Rohmann
CEO & Co-Founder
Asclepiceuticals AI